Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Vamsidhar Velcheti, MD


Vamsidhar Velcheti, MD
Department: Hematology and Oncology
Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:
Adults Only

Biographical Sketch

Vamsidhar Velcheti, MD, is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine and staff physician in the Department of Hematology and Oncology at Cleveland Clinic Taussig Cancer Institute. His specialty areas include lung cancer, mesothelioma, and thymic tumors and the use of novel immunotherapies for the treatment of lung cancer. Dr. Velcheti’s clinical and translational research focuses on identifying patients with molecular changes in the tumor that can predict response to immunotherapy and expanding clinical trials focusing on immunotherapy and novel agents. Dr. Velcheti received his hematology/oncology fellowship training at the Yale-Comprehensive Cancer Center in New Haven, Connecticut. 

Education & Fellowships

Fellowship - Yale-New Haven Hospital
New Haven, CT USA
Residency - Ochsner Medical Center
Internal Medicine
Jefferson, LA
Medical School - Armed Forces Medical College
Pune India


  • Internal Medicine
  • Internal Medicine- Medical Oncology

Awards & Honors

  • The Edward D. Frohlich, MD, Research Award, Ochsner Clinic Foundation, 06/2010
  • Young Investigator Award, American Society of Clinical Oncology, 06/2012
  • Young Investigator Travel grant, American Society of Clinical Oncology/European Organization for Research and Treatment of Cancer/National Cancer Institute, 10/2012
  • Outstanding Researcher Award-2013, Hematology & Oncology fellowship program, Yale School of Medicine, 06/2013
  • Merit Award, American Society of Clinical Oncology, 06/2013
  • Career Development Award, American Society of Clinical Oncology, 06/2015


  • The Society for Immunotherapy of Cancer (SITC) Member June 2013 – Present
  • American Society for Clinical Oncology Member March 2010 – Present
  • The International Association for the Study of Lung Cancer (IASLC) Member June 2013 – Present
  • International Thymic Malignancy Interest Group Member June 2013 – Present

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/28/2016, Dr. Velcheti has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English

Patient Satisfaction Reviews

Learn About Our Survey


The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.